What we do: NIDDK Research Areas and Technologies
NIDDK conducts and supports research on many chronic and costly diseases affecting public health: diabetes, obesity, nutrition, digestive disorders, endocrine and metabolic disorders, hematologic diseases, and kidney and urologic diseases, as well as complications from HIV infection. NIDDK’s biomedical research efforts could be generally characterized as “internal medicine”-oriented as they relate to the medical specialties of endocrinology, gastroenterology, hematology, infectious disease, and nephrology. NIDDK employs clinicians who conduct and manage clinical research studies on these various diseases. NIDDK employs medicinal chemists, who conduct research to synthesize and evaluate both macro-molecules and small molecules, including agonists and antagonists to G protein-coupled receptors (GPCRs) such as Thyroid Stimulating Hormone (TSH), Adenosine, and 5-Hydroxytryptamine (5-HT) receptors. In addition, NIDDK employs biologists and process scientists who create a vast array of technologies ranging from cell lines to transgenic and knock-out mouse models.
For more information, please view our online catalog, which describes NIDDK’s experimental compounds, mouse models, cell lines, and antibodies that are available for research, development and/or and commercialization. In addition, please view our listings of NIDDK patented inventions.
The NIDDK TAO is eager to assist you in identifying NIDDK technologies of potential interest to your organization for further research, development and/or commercialization. Please contact us to explore opportunities to access NIDDK discoveries that meet your technology needs.
Page last updated: December 29, 2010